Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

The degree of obesity may influence the outcomes of acute pancreatitis (opens in a new tab)

medicalxpress.com · 2026-10-27

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 4 supported
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly supported

Every claim we could check holds up. Four of five claims match the study. This overall rating is based only on the claims we could check. One claim the study doesn't address.

  • 4 supported
  • 1 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredThe researchers suggest that chronic low-grade inflammation, comorbidities, and physical problems related to severe obesity may help explain why obesity worsens the course of acute pancreatitis, and they say even gradual or smaller weight loss might be effective.View evidenceHide evidence

As statedeven gradual or smaller weight loss might be effective

Why this verdict

The abstract-level profile supports parts of this claim only generally: it reports dose-dependent increases in pre-existing comorbidities/complications and notes that gradual weight loss and patient education may be beneficial or warrant investigation. However, the specific proposed mechanisms listed in the story—chronic low-grade inflammation and physical problems related to severe obesity—are not present in the abstract-level evidence supplied. At this evidence depth, the full mechanistic claim cannot be verified.

1

Study evidence

Distribution of patients across WHO BMI categories: 2.8% underweight, 30.0% normal, 35.0% overweight, 20.0% obesity class I, 8.2% obesity class II, 3.7% obesity class III.

“Anamnestic, admission, and outcome parameters were analyzed.”
2

Study evidence

The authors state that obesity increases the odds of pre-existing comorbidities and complications in a dose-dependent manner across BMI categories.

“Obesity dose-dependently elevates the odds of pre-existing comorbidities and complications.”
Claim 2 of 5SupportedIn acute pancreatitis, mild obesity might more than double the odds of vital organ failure, according to an international study by researchers at Semmelweis University analyzing data from more than 2,200 patients.View evidenceHide evidence

As statedmore than double the odds

Why this verdict

The abstract-level profile reports an international registry cohort of 2,244 acute pancreatitis patients and multivariable models showing obesity class I had OR=2.12 for organ failure versus normal weight, which supports the headline's hedged, associational statement that mild obesity might more than double the odds of organ failure. The headline does not overrun the evidence so long as it is read as an association, not causation.

1

Study evidence

Higher obesity class was associated with increased odds of organ failure in multivariable models.Obesity class I: OR = 2.12 (95% CI 1.29–3.46, p = 0.003); class II: OR = 2.57 (95% CI 1.40–4.71, p = 0.002); class III: OR = 2.71 (95% CI 1.25–5.89, p = 0.012).

“In total, 2244 AP cases from 13 countries and 29 centers of the Acute Pancreatitis Registry ... were included”
Claim 3 of 5SupportedThe study, published in the journal Pancreatology, found that patients with obesity may have more than three times the odds of developing severe acute pancreatitis compared with patients of normal weight.View evidenceHide evidence

As statedmore than three times the odds

Why this verdict

The profile reports higher odds of severe acute pancreatitis in obesity classes I–III, with class I OR=3.16 and class II OR=3.98, supporting the hedged statement that patients with obesity may have more than three times the odds. Nuance: obesity class III was reported as OR=2.80, so the “more than three times” magnitude is not true for every obesity class, but the claim’s 'may' framing is broadly consistent with the abstract evidence.

1

Study evidence

Higher obesity class was associated with increased odds of organ failure in multivariable models.Obesity class I: OR = 2.12 (95% CI 1.29–3.46, p = 0.003); class II: OR = 2.57 (95% CI 1.40–4.71, p = 0.002); class III: OR = 2.71 (95% CI 1.25–5.89, p = 0.012).

“In total, 2244 AP cases from 13 countries and 29 centers of the Acute Pancreatitis Registry ... were included”
Claim 4 of 5SupportedResearchers at Semmelweis University analyzed data from 2,244 patients with acute pancreatitis across 29 health care centers in 13 countries and categorized them by BMI and degree of obesity.View evidenceHide evidence

As stated2,244 patients; 29 centers; 13 countries

Why this verdict

The profile directly states that 2,244 acute pancreatitis cases from 13 countries and 29 centers were included and that patients were grouped by WHO BMI categories. This matches the story’s description of the dataset and exposure categorization.

1

Study evidence

Higher obesity class was associated with increased odds of organ failure in multivariable models.Obesity class I: OR = 2.12 (95% CI 1.29–3.46, p = 0.003); class II: OR = 2.57 (95% CI 1.40–4.71, p = 0.002); class III: OR = 2.71 (95% CI 1.25–5.89, p = 0.012).

“In total, 2244 AP cases from 13 countries and 29 centers of the Acute Pancreatitis Registry ... were included”
2

Study evidence

Distribution of patients across WHO BMI categories: 2.8% underweight, 30.0% normal, 35.0% overweight, 20.0% obesity class I, 8.2% obesity class II, 3.7% obesity class III.

“Anamnestic, admission, and outcome parameters were analyzed.”
Claim 5 of 5SupportedThe article says the odds of organ failure were more than twice as high even in mild obesity, and that the higher the degree of obesity, the higher these odds became.View evidenceHide evidence

As statedmore than twice as high

Why this verdict

The profile reports organ-failure odds increasing across obesity classes: class I OR=2.12, class II OR=2.57, and class III OR=2.71. This supports the statement that odds were more than twice as high even in mild obesity and rose with higher obesity degree.

1

Study evidence

Higher obesity class was associated with increased odds of organ failure in multivariable models.Obesity class I: OR = 2.12 (95% CI 1.29–3.46, p = 0.003); class II: OR = 2.57 (95% CI 1.40–4.71, p = 0.002); class III: OR = 2.71 (95% CI 1.25–5.89, p = 0.012).

“In total, 2244 AP cases from 13 countries and 29 centers of the Acute Pancreatitis Registry ... were included”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Limitation: the abstract does not specify covariates included in multivariable models

    The story does not mention that the abstract-level evidence lacks details on model adjustment. This is material because unreported covariates affect how confidently the odds ratios can be interpreted.

    From Multicenter observational registry cohort; Multicenter registry cohort analysis (BMI-category stratified, multivariable

8 things the story did carry across
  • International multicenter observational registry cohort design, not an interventional or causal study
  • Cohort size and setting: 2,244 acute pancreatitis cases from 29 centers in 13 countries
  • Exposure definition: patients were categorized by WHO BMI categories, including obesity classes I–III
  • Primary outcome finding: higher obesity class was associated with higher odds of organ failure, with class I OR=2.12, class II OR=2.57, and class III OR=2.71
  • Primary outcome finding: obesity classes I–III had higher odds of severe acute pancreatitis, with ORs 3.16, 3.98, and 2.80
  • Secondary finding: obesity was reported to dose-dependently elevate odds of pre-existing comorbidities and complications
  • Authors’ suggestion that gradual weight loss and patient education may be beneficial and warrant investigation
  • Limitation: observational registry data cannot establish causality and may be affected by residual confounding
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataQuantify the association between degree of obesity (BMI categories) and acute pancreatitis severity/outcomes (e.g., organ failure, severe AP) in an international multicenter registry cohort using multivariable logistic regression.Multicenter observational registry cohortExpand

In plain English

In a 2244-patient, multicenter international registry cohort of acute pancreatitis (13 countries, 29 centers), patients were categorized by WHO BMI classes. Logistic and multivariable logistic regression were used to estimate associations between BMI category and outcomes (organ failure, severe acute pancreatitis), reporting odds ratios (ORs) with 95% confidence intervals (CIs). Higher obesity classes were associated with increased odds of organ failure and of severe AP in multivariable models.

Key findings

  • Higher obesity class was associated with increased odds of organ failure in multivariable models.Obesity class I: OR = 2.12 (95% CI 1.29–3.46, p = 0.003); class II: OR = 2.57 (95% CI 1.40–4.71, p = 0.002); class III: OR = 2.71 (95% CI 1.25–5.89, p = 0.012).
  • Obesity classes I–III had higher odds of severe acute pancreatitis in multivariable models.Obesity class I: OR = 3.16 (95% CI 1.71–5.83, p < 0.001); class II: OR = 3.98 (95% CI 1.95–8.15, p < 0.001); class III: OR = 2.80 (95% CI 1.05–7.48, p = 0.040).
“In total, 2244 AP cases from 13 countries and 29 centers of the Acute Pancreatitis Registry ... were included”
What this piece can’t prove
  • Observational registry data; associations may be affected by residual confounding and cannot establish causality.
  • Abstract does not report which covariates were adjusted for in multivariable models.

2 further details could not be confirmed from the summary.

2secondary dataDescribe baseline/anamnestic and admission characteristics (including pre-existing comorbidities) across BMI categories in the acute pancreatitis cohort.multicenter registry cohortExpand

In plain English

In a 2244-patient, multicenter registry of acute pancreatitis, the authors stratified patients into WHO BMI categories and reported/analyzed anamnestic (history/comorbidities) and admission parameters across those BMI groups. The abstract provides the cohort BMI distribution and states that obesity was associated with higher odds of pre-existing comorbidities in a graded (dose-dependent) manner, but does not present category-specific comorbidity prevalences or detailed admission parameter summaries in the abstract.

Key findings

  • Distribution of patients across WHO BMI categories: 2.8% underweight, 30.0% normal, 35.0% overweight, 20.0% obesity class I, 8.2% obesity class II, 3.7% obesity class III.
  • Authors report that obesity dose-dependently elevates the odds of pre-existing comorbidities across BMI groups.
“Anamnestic, admission, and outcome parameters were analyzed.”
What this piece can’t prove
  • Abstract does not report category-specific prevalences for individual comorbidities or detailed admission parameters (clinical/laboratory) by BMI group.
  • Evidence here is limited to abstract statements; full-text tables and methods are needed to appraise quality of baseline/admission reporting.

1 further detail could not be confirmed from the summary.

3secondary dataAssess the relationship between degree of obesity and acute pancreatitis complications/comorbidity burden beyond the primary severity endpoints (as framed in the conclusion: comorbidities and complications increase dose-dependently).Multicenter registry cohort analysis (BMI-category stratified, multivariable logistic regression)Expand

In plain English

In a 2244-patient multicenter registry cohort, the authors report that increasing degree of obesity is associated with a dose-dependent increase in the odds of pre-existing comorbidities and complications in acute pancreatitis. The abstract does not provide outcome-level definitions, effect estimates, or modelling covariates for these comorbidity/complication analyses.

Key findings

  • The authors state that obesity increases the odds of pre-existing comorbidities and complications in a dose-dependent manner across BMI categories.
“Obesity dose-dependently elevates the odds of pre-existing comorbidities and complications.”
What this piece can’t prove
  • Unclear whether the comorbidity/complication findings are independent of the severity endpoints (organ failure, severe AP) or represent overlapping outcomes.

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

The degree of obesity correlates with the severity of acute pancreatitis: An international multicenter cohort analysis of 2244 patients

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2026

Deep dive in Tessa (opens in a new tab)Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 16 candidate papers

Selected

The degree of obesity correlates with the severity of acute pancreatitis: An international multicenter cohort analysis of 2244 patients

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.] · 2026 · PubMed, Europe PMC, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

Low Mortality and High Morbidity in Severe Acute Pancreatitis Without Organ Failure

American Journal of Gastroenterology · 2009 · Crossref

Source (opens in a new tab)

And 10 more candidates considered.